Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.
J Med Toxicol. 2021 Jul;17(3):289-308. doi: 10.1007/s13181-020-00819-y. Epub 2021 Jan 5.
The USA is in an opioid epidemic, with an increased number of individuals taking psychoactive drugs while executing the tasks of everyday life, including operating a motor vehicle. The pharmacology of opioids has been widely studied, but the effects of opioids on psychomotor function, driving performance, and the risk of motor vehicle collision remain less clear. Clinicians are faced with the challenge of controlling patient pain while also reconciling conflicting messages from the literature about how safe it is for their patients taking opioids to engage in potentially dangerous routine tasks.
This review assesses the current literature regarding opioids as they relate to neurocognitive function, driving performance, and accident risk. Manuscripts are categorized by study context and subject matter: controlled experimental administration, illicit use, prescription use, retrospective forensic toxicology, and polydrug consumption.
Illicit use, initiation of therapy, and opioid use in combination with other psychoactive medications are contexts most clearly associated with impairment of driving-related functions and/or operation of a motor vehicle. Clinicians should counsel patients on the risk of impairment when initiating therapy, when co-prescribing opioids and other psychoactive drugs, or when a patient is suspected of having an opioid use disorder.
美国正处于阿片类药物泛滥的困境之中,越来越多的人在执行日常生活任务时(包括驾驶机动车辆)服用精神活性药物。阿片类药物的药理学已经得到了广泛的研究,但阿片类药物对精神运动功能、驾驶表现和发生机动车碰撞的风险的影响仍不明确。临床医生面临着控制患者疼痛的挑战,同时也需要面对来自文献中的相互矛盾的信息,这些信息涉及他们的患者在服用阿片类药物时参与潜在危险的日常任务的安全性。
这篇综述评估了目前关于阿片类药物与神经认知功能、驾驶表现和事故风险相关的文献。文献按研究背景和主题分类:受控实验管理、非法使用、处方使用、回顾性法医毒理学和多药物消费。
非法使用、开始治疗以及阿片类药物与其他精神活性药物联合使用,与驾驶相关功能和/或机动车操作受损最明显相关。当开始治疗、同时开处阿片类药物和其他精神活性药物或怀疑患者有阿片类药物使用障碍时,临床医生应告知患者损伤风险。